The study aimed to establish whether suppressing inflammation through aggressive treatment can act as a protective factor against cognitive decline. 2.2 Cardiovascular and Cerebrovascular Comorbidities
Following years of comprehensive clinical practice in India, Dr. Kodishala transitioned to global clinical research. He joined the Division of Rheumatology at the Mayo Clinic as a post-doctoral research fellow.
His research has established several important findings:
If you are interested in exploring specific areas of rheumatology further, I can provide: Chanakya Kodishala
Dr. Kodishala's expertise has been recognized by the international medical community. He was invited as a speaker at the , scheduled to take place in Tokyo, Japan. He has also been listed as a participant at the American College of Rheumatology (ACR) Convergence 2023 .
Chanakya Kodishala was established with a clear purpose: to create a community of scholars who could engage in rigorous intellectual discourse, exploring the intricacies of various disciplines, including philosophy, economics, politics, and the arts. The institution was designed to be a hub of interdisciplinary learning, where students could engage with the most pressing issues of their time. By fostering a culture of critical thinking, debate, and intellectual curiosity, Chanakya Kodishala aimed to produce a new generation of leaders, thinkers, and visionaries who could shape the future of India.
Chanakya Kodishala: A Leading Voice in Rheumatological Research He joined the Division of Rheumatology at the
His work extends into global initiatives, such as the MYONET registry , where he serves as a collaborator analyzing rare conditions like anti-synthetase syndrome across international patient groups results from the MYONET registry. Core Research Focus Areas
While the name might evoke the ancient strategist Chanakya (Kautilya), this modern-day Chanakya is scripting a different kind of conquest—one that bridges the gap between traditional Telugu cinema fandom and the global language of digital content. To understand the current shift in South Indian entertainment marketing, one must look at the methodology and vision of Chanakya Kodishala.
The KodiVerse is not just a production house; it is an ecosystem. Under the leadership of Chanakya Kodishala, The KodiVerse has redefined how movie trailers, teasers, and digital promos are cut. Here is what makes his approach different: He was invited as a speaker at the
#Rheumatology #MedicalResearch #DementiaAwareness #MayoClinic #RAResearch" Option 2: Conference Participation/Award (Community Style)
Strong statistical associations have been noted between baseline anxiety, depression, and subsequent neurodegeneration in autoimmune cohorts. Global Contributions to Autoimmune and Viral Interaction
Dr. Chanakya Kodishala began his medical journey with a focus on comprehensive internal medicine and rheumatology. He earned his MBBS (Bachelor of Medicine, Bachelor of Surgery) degree in India, where he gained initial experience in systemic diseases and autoimmune conditions.
In seminal population-based cohort studies using extensive data from Minnesota healthcare systems, Dr. Kodishala and fellow researchers analyzed the exact pathways connecting RA to cognitive decline. A notable area of his focus is the of cardiovascular (CVD) and cerebrovascular diseases (CeVD).
"Excited to share our latest research published in The Journal of Rheumatology regarding the risk factors for dementia in patients with incident Rheumatoid Arthritis. Our population-based cohort study highlights that beyond universal factors like age and hypertension, clinically active RA and cardiovascular disease significantly elevate this risk.
